Atlas Trials

A Prospective Randomized Comparison of HDAC Vs AD in the Induction Chemothrapy for AML.

Clinical trial NCT03507842 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT03507842
Sponsor
Asan Medical Center
Status
ENROLLING_BY_INVITATION
Phase
Phase 3
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2018-03-01
Primary completion
2028-12-31
Enrollment
380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.